We report a case of acute psoriasiform contact dermatitis of the forehead and scalp related to the use of a low-laser light cap. The patient had a positive patch test to dimethylol dihydroxyethyleneurea (DMDE), methylisothiazolinone, kathon CG, and cobalt. We believe that DMDE in the fabric of the cap was responsible for the allergic contact dermatitis in this case as the lesions resolved with cessation of cap use.

1.
Jimenez JJ, Wikramanayake TC, Bergfeld W, Hordinsky M, Hickman JG, Hamblin MR, Schachner LA: Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study. Am J Clin Dermatol 2014;15:115-127.
2.
Scheman AJ, Carroll PA, Brown KH, Osburn AH: Formaldehyde-related textile allergy: an update. Contact Dermatitis 1998;38:332-336.
3.
Metzler-Brenckle L, Rietschel RL: Patch testing for permanent-press allergic contact dermatitis. Contact Dermatitis 2002;46:33-37.
4.
Bolognia J, Jorizzo JL, Schaffer JV: Dermatology (ed 3). Philadelphia, Elsevier Saunders, 2012, vol 1, pp 209-240.
5.
Lazarov A, Cordoba M: Purpuric contact dermatitis in patients with allergic reaction to textile dyes and resins. J Eur Acad Dermatol Venerol 2000;14:101-105.
6.
Mestach L, Goossens A: Allergic contact dermatitis and nail damage mimicking psoriasis caused by nail hardeners. Contact Dermatitis 2015;74:112-114.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.